- Investigator
- Gurjit S Kaeley
- Ages
- 18 Years - 75 Years
- Sexes
- All
Clinical trials
-
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants with Active Systemic Lupus Erythematosus (SLE) -
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (20210052) - Investigator
- Vandana K Seeram
- Ages
- 40 Years - 99 Years
- Sexes
- All
-
RUBENS Trial - Investigator
- Jose R Rivas Rios
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
TAILOR BLEED - Investigator
- Dominick J Angiolillo
- Ages
- N/A
- Sexes
- All
-
Rare Disease Registry - Investigator
- Pamela L Trapane
- Ages
- 0 Years - 100 Years
- Sexes
- All
-
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Investigate the Efficacy and Safety of Asapiprant in Hospitalized Adults With COVID-19 - Investigator
- Carmen Isache
- Ages
- N/A
- Sexes
- All
-
A Multi-Center Phase 2/3 Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Safety and Efficacy Study of Dapansutrile Tablets in Subjects with an Acute Gout Flare - Investigator
- Gurjit S Kaeley
- Ages
- 18 Years - 100 Years
- Sexes
- All
-
A Phase 3, Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis (PFI) (Also Known as Ledderhose Disease) - Investigators
- John S Anderson, Jason A Piraino
- Ages
- 18 Years - N/A
- Sexes
- All